Chesnara Plc: Fourth acquisition in two years
12 November 2026
Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare industry, presents a compelling opportunity for investors as it navigates the complexities of the pharmaceutical..
Humana Inc. (NYSE: HUM) stands as a formidable player in the healthcare plans industry, a sector that continues to experience robust demand and growth prospects. With..
Centene Corporation (NYSE: CNC), a leading player in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With a..
Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector, stands at the forefront of revolutionizing minimally invasive surgical procedures. With a market capitalization of..
For investors seeking opportunities within the healthcare sector, Elevance Health, Inc. (NYSE: ELV) presents a compelling case with a formidable market presence and promising financial indicators...
argenx SE (NASDAQ: ARGX), a Netherlands-based biotech powerhouse, continues to command attention in the healthcare sector with its robust pipeline of therapies targeting a range of..
GE HealthCare Technologies Inc. (NYSE: GEHC), a key player in the healthcare sector, is drawing attention from investors with a notable potential upside of 19.9%. As..
Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to capture investor attention with its robust dividend yield and promising potential upside. With a..
Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to hold a significant position in the global biopharmaceutical landscape. With a market capitalization..
Abbott Laboratories (NYSE: ABT) stands out in the healthcare sector, particularly within the medical devices industry, with a market capitalization of $229.31 billion. Abbott’s diverse operations..
HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable entity in the U.S. healthcare sector, commanding a market capitalization of approximately $92.61 billion. As a prominent..
Gilead Sciences, Inc. (GILD), a titan in the healthcare sector with a market capitalization of $146.87 billion, stands as a beacon of innovation in the biopharmaceutical..
AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to attract investor attention with its robust portfolio of pharmaceutical products and a promising upside..
Tourmaline Bio, Inc. (NASDAQ: TRML), a burgeoning name in the biotechnology sector, is capturing investor attention with its promising pipeline and substantial growth potential. Specializing in..
Fortrea Holdings Inc. (NASDAQ: FTRE) is carving out its niche in the competitive biotechnology sector, with a market capitalization of $717.32 million. As a contract research..
Myriad Genetics, Inc. (NASDAQ: MYGN) presents a curious case for investors in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Salt Lake..
Rapport Therapeutics, Inc. (NASDAQ: RAPP), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its focus on developing transformational small molecule medicines for..
Septerna, Inc. (SEPN) is catching the eye of savvy investors with its promising ventures in the biotechnology sector. Headquartered in South San Francisco, this clinical-stage company..
Inventiva S.A. (IVA), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising portfolio of oral small molecule therapies. Headquartered in Daix, France,..
For investors keeping an eye on the healthcare sector, and specifically the medical devices industry, Standard BioTools Inc. (NASDAQ: LAB) presents a fascinating opportunity. Headquartered in..
